Dystrophic Epidermolysis Bullosa Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key Players- RegeneRx, Amryt Pharma, Abeona Therapeutics, Krystal Biotech, Fibrocell Technologies